Identification of a Novel Kindred with Familial Pancreatitis and Pancreatic Cancer

Background/Aims: Hereditary pancreatic cancer comprises about 10% of pancreatic cancer cases. Multiple causative mutations have been identified. Here we describe a pancreatitis/pancreatic cancer (P/PC) family, which demonstrates pancreatitis and pancreatic cancer resulting from an uncharacterized mutation. Methods: Family members completed evaluations to determine signs of mutation status. Select patients were screened for mutations associated with hereditary pancreatic diseases. Results: In generation II, 12 siblings exhibit 6 cases of pancreatitis, 3 pancreatic cancer, and 2 obligate carrier status. The average age at pancreatitis diagnosis of enrolled members is 32.5 years; average age at pancreatic cancer diagnosis is 59 years. There is no association with known cancer syndromes. Those affected generally present with mild epigastric pain, and CT scans demonstrate characteristic fatty infiltration of the pancreatic body and tail with sparing of the head and neck. Full sequence analysis of genes associated with hereditary pancreatic disease failed to demonstrate known mutations or polymorphisms. Conclusion: Based upon pedigree evaluation and preliminary DNA analysis, we believe that the family members with P/PC carry a novel genetic mutation resulting in hereditary pancreatitis. This mutation is autosomal dominant, expressed with high penetrance, and is part of a unique hereditary syndrome that significantly increases pancreatic cancer risk.

[1]  Tatjana Crnogorac-Jurcevic,et al.  Palladin Mutation Causes Familial Pancreatic Cancer and Suggests a New Cancer Mechanism , 2006, PLoS medicine.

[2]  M. de Andrade,et al.  Cystic fibrosis transmembrane regulator gene carrier status is a risk factor for young onset pancreatic adenocarcinoma , 2005, Gut.

[3]  A. Schneider Serine protease inhibitor kazal type 1 mutations and pancreatitis. , 2005, Clinics in laboratory medicine.

[4]  P. Jowell,et al.  The impact of cystic fibrosis and PSTI/SPINK1 gene mutations on susceptibility to chronic pancreatitis. , 2005, Clinics in laboratory medicine.

[5]  W. Greenhalf,et al.  Cationic trypsinogen mutations and pancreatitis. , 2004, Clinics in laboratory medicine.

[6]  S. Hahn,et al.  Genetics of hereditary pancreatic carcinoma. , 2005, Gastroenterology clinics of North America.

[7]  R. Brand,et al.  Identification of high-risk pancreatic cancer-prone families. , 2004, Gastroenterology clinics of North America.

[8]  T. Brentnall,et al.  Inherited pancreatic cancer: improvements in our understanding of genetics and screening. , 2004, The international journal of biochemistry & cell biology.

[9]  R. Wolff,et al.  Pancreatic cancer , 2004, The Lancet.

[10]  M. Ogawa,et al.  Hereditary Pancreatitis: Clinical Characteristics and Diagnostic Criteria in Japan , 2004, Pancreas.

[11]  P. Maisonneuve,et al.  Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. , 2003, Gastroenterology.

[12]  D. Bartsch Familial pancreatic cancer , 2003, The British journal of surgery.

[13]  Alicia Samuels,et al.  Cancer Statistics, 2003 , 2003, CA: a cancer journal for clinicians.

[14]  R. DePinho,et al.  Pancreatic cancer biology and genetics , 2002, Nature Reviews Cancer.

[15]  M. Lerch,et al.  Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. , 2001, JAMA.

[16]  S. Goodman,et al.  Very high risk of cancer in familial Peutz-Jeghers syndrome. , 2000, Gastroenterology.

[17]  N. Gruis,et al.  Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16‐Leiden) , 2000, International journal of cancer.

[18]  M. Barmada,et al.  SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. , 2000, Gastroenterology.

[19]  Olfert Landt,et al.  Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis , 2000, Nature Genetics.

[20]  P Maisonneuve,et al.  Risk factors for cancer in hereditary pancreatitis. International Hereditary Pancreatitis Study Group. , 2000, The Medical clinics of North America.

[21]  D. Whitcomb Hereditary pancreatitis: new insights into acute and chronic pancreatitis , 1999, Gut.

[22]  M. Gorry,et al.  Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. , 1997, Gastroenterology.

[23]  E. Dimagno,et al.  Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. , 1997, Journal of the National Cancer Institute.

[24]  M. Gorry,et al.  Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene , 1996, Nature Genetics.

[25]  Yingze Zhang,et al.  A gene for hereditary pancreatitis maps to chromosome 7q35. , 1996, Gastroenterology.

[26]  R H Hruban,et al.  Familial pancreatic cancer: a review. , 1996, Seminars in oncology.

[27]  P. Blind Pancreatic Secretory Enzymes in the Diagnosis of Acute Pancreatitis , 1993 .

[28]  P. Boyle,et al.  Life‐time history of smoking and exocrine carcinoma of the pancreas: A population‐based case‐control study in the Netherlands , 1991, International journal of cancer.

[29]  J. Gross,et al.  Hereditary pancreatitis. Description of a fifth kindred and summary of clinical features. , 1962, The American journal of medicine.

[30]  A. Steinberg,et al.  Pedigree of a family with hereditary chronic relapsing pancreatitis. , 1952, Gastroenterology.